Revenue for the nine months ended September 2024 was ₩313.95 billion, with net income of ₩10.50 billion, both declining year-over-year. The EMS segment remains the core revenue driver, and the company executed treasury stock buybacks and maintained a strong balance sheet.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.